Bone-marrow transplantation in sickle-cell disease. Effect on osteonecrosis: a case report with a four-year follow-up.
Hernigou
P
P
Hôpital Henri Mondor, Creteil, France.
Bernaudin
F
F
Reinert
P
P
Kuentz
M
M
Vernant
J P
JP
D000293:Adolescent; D000743:Anemia, Hemolytic / Q000150:complications; D000755:Anemia, Sickle Cell / Q000150:complications / Q000628:therapy*; D016026:Bone Marrow Transplantation; D001861:Bone Regeneration; D002066:Busulfan / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D006811:Humerus / Q000473:pathology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015182:Lymphatic Irradiation; D008297:Male; D010020:Osteonecrosis / Q000209:etiology / Q000628:therapy*; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003520:Cyclophosphamide; D002066:Busulfan